Biotinylated Human SOST / Sclerostin Protein, His Tag, ultra sensitivity (primary amine labeling)

Artikelnummer: ABS-SOT-H8245-200UG
Artikelname: Biotinylated Human SOST / Sclerostin Protein, His Tag, ultra sensitivity (primary amine labeling)
Artikelnummer: ABS-SOT-H8245-200UG
Hersteller Artikelnummer: SOT-H8245-200ug
Alternativnummer: ABS-SOT-H8245-200UG
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: Biotin
Sclerostin (SOST) is also known as Sclerosteosis, VBCH, is a secreted glycoprotein with a signal peptide for secretion and a Cterminal cysteine knotlike (CTCK) domain and belongs to the Cerberus/DAN family of bone morphogenetic protein (BMP) antagonists. Sclerostin is produced by the osteocyte and has antianabolic effects on bone formation. More recently Sclerostin has been identified as binding to LRP5/6 receptors and inhibiting the Wnt signalling pathway. Wnt pathway inhibition under these circumstances is antagonistic to bone formation (meaning Sclerostin antagonizes bone formation). It has been shown that SOST binds BMP5, 6, and 7 with high affinity and BMP2 and 4 with low affinity. Sclerostin production by osteocytes is inhibited by parathyroid hormone, mechanical loading and cytokines including oncostatin M, cardiotrophin1 and leukemia inhibitory factor. Sclerostin production is increased by calcitonin. Thus, osteoblast activity is self regulated by a negative feedback system. Mutations of Sclerostin is associated with the syndrome Sclerosteosis, and reduced sclerostin expression results in a milder form of the disorder called van Buchem disease. - Proteine/Peptide
Molekulargewicht: 22.3 kDa
Tag: N-6*His
NCBI: 01087
Puffer: PBS, pH7.4
Expression System: Gln 24 - Tyr 213
Reinheit: 95%
Formulierung: Powder
Target-Kategorie: SOST
SOT-H8245-200ug